These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10582551)

  • 21. Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats.
    Santuré M; Pitre M; Nadeau A; Bachelard H
    Metabolism; 2003 Aug; 52(8):978-86. PubMed ID: 12898461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
    Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
    Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
    Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
    Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
    Chicco A; Basabe JC; Karabatas L; Ferraris N; Fortino A; Lombardo YB
    Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Troglitazone stimulates pancreatic growth in normal rats.
    Jia DM; Otsuki M
    Pancreas; 2002 Apr; 24(3):303-12. PubMed ID: 11893940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes.
    Meyer MM; Levin K; Grimmsmann T; Perwitz N; Eirich A; Beck-Nielsen H; Klein HH
    Diabetes; 2002 Sep; 51(9):2691-7. PubMed ID: 12196460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes.
    Levin K; Hother-Nielsen O; Henriksen JE; Beck-Nielsen H
    Diabetes Care; 2004 Jan; 27(1):148-54. PubMed ID: 14693981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Troglitazone reduces free fatty acid-induced insulin resistance in perfused rat hindquarter.
    Mokuda O; Sakamoto Y
    Diabetes Metab; 1998 Sep; 24(4):362-4. PubMed ID: 9805648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats.
    Fonseca V; Keebler M; Dicker-Brown A; Desouza C; Poirier LA; Murthy SN; McNamara DB
    Metabolism; 2002 Jun; 51(6):783-6. PubMed ID: 12037736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus.
    Shimizu K; Shiratori K; Hayashi N; Fujiwara T; Horikoshi H
    Pancreas; 2000 Nov; 21(4):421-6. PubMed ID: 11075998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.
    Zhang B; Saku K; Arakawa K
    Metabolism; 1997 Mar; 46(3):273-81. PubMed ID: 9054469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
    J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro.
    Fürnsinn C; Neschen S; Noe C; Bisschop M; Roden M; Vogl C; Schneider B; Waldhäusl W
    Br J Pharmacol; 1997 Dec; 122(7):1367-74. PubMed ID: 9421284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
    Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
    J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats.
    Fujiwara T; Ohsawa T; Takahashi S; Ikeda K; Okuno A; Ushiyama S; Matsuda K; Horikoshi H
    Life Sci; 1998; 63(22):2039-47. PubMed ID: 9839548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats.
    Jia DM; Fukumitsu KI; Tabaru A; Akiyama T; Otsuki M
    Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1332-40. PubMed ID: 11294751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
    Bähr M; Spelleken M; Bock M; von Holtey M; Kiehn R; Eckel J
    Diabetologia; 1996 Jul; 39(7):766-74. PubMed ID: 8817100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects.
    Gabriely I; Wozniak R; Hawkins M; Shamoon H
    J Clin Endocrinol Metab; 2001 Feb; 86(2):521-8. PubMed ID: 11158003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.